跳至主要内容
临床试验/NCT03708276
NCT03708276已完成不适用

Testing a New Multiple Sclerosis Specific Web-based Symptom Self-management Program: My MS Toolkit

University of Michigan1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年2月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Acceptability of My MS Toolkit

研究概览

简要总结

My MS Toolkit is a web-based symptom self-management program for persons with multiple sclerosis.

This study is evaluating various aspects of My MS Toolkit and how it impacts symptom self-management in multiple sclerosis. The research team believe that the toolkit will be feasible, acceptable, and beneficial to participants.

详细描述

Study participants will be asked to use a newly developed web-based symptom self-management program, called the My MS Toolkit, for 12 weeks. Participants will also be asked to complete online surveys throughout the study.

The My MS Toolkit includes 8 modules that describe symptom self-management strategies. Participants will explore the My MS Toolkit on their own, following the prompts and guides built into the program, and are encouraged to practice and apply the skills learned.

The study can be done from participants' homes using a reliable internet-connected device. No travel is required.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Multiple Sclerosis
  • •Have access to a reliable, internet-connected device (e.g. computer, tablet). (Note: this study is conducted electronically and is not location dependent.)
  • •One or more of the following:
  • •Moderate/moderately severe depressive symptoms
  • •Chronic pain
  • •Presence of significant fatigue symptoms
  • •Read, speak and understand English.

排除标准

  • •Significant cognitive impairment
  • •Current psychotherapy for symptoms

研究组 & 干预措施

My MS Toolkit

Experimental

20 Participants asked to use My MS Toolkit.

干预措施: My MS Toolkit (Other)

结局指标

主要结局

Acceptability of My MS Toolkit

时间窗: week 12-week 14

Assessed by the Patient Satisfaction Evaluation Scale, 12 question scale where each response score ranges from 4 to 1 and the total score ranges from 48 to 12. Higher scores indicate increased satisfaction.

Feasibility of My MS Toolkit

时间窗: up to week 12

Assessed by the treatment adherence questionnaire that consists of 5 questions that assess: 1) how many times the participant accessed the website in the prior two weeks; 2) how many minutes the participant spent on the website; 3) which parts of the website the participant accessed; 4) which activities the participant engaged in; and 5) which skill from the website the participant used. The items on this questionnaire will be used to describe the use of the website for assessing treatment adherence by participants in the study.

次要结局

  • Impact My MS Toolkit: Change in pain interference(up to 14 weeks)
  • Impact My MS Toolkit: Change in depressive symptoms(up to 14 weeks)
  • Change in self-efficacy for managing symptoms(up to 14 weeks)
  • Impact of My MS Toolkit: Change in fatigue(Pre- and post-treatment, up to 14 weeks)
  • Participant perception of change(week 12-14)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anna Kratz

Associate Professor of Physical Medicine and Rehabilitation

University of Michigan

研究点 (1)

Loading locations...

相似试验